These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1341046)

  • 1. Activation of muscle-specific transcription by myogenic helix-loop-helix proteins.
    Olson E
    Symp Soc Exp Biol; 1992; 46():331-41. PubMed ID: 1341046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
    Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
    Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle.
    Davie JK; Cho JH; Meadows E; Flynn JM; Knapp JR; Klein WH
    Dev Biol; 2007 Nov; 311(2):650-64. PubMed ID: 17904117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation domain of the muscle-specific gene-regulatory protein myf5.
    Braun T; Winter B; Bober E; Arnold HH
    Nature; 1990 Aug; 346(6285):663-5. PubMed ID: 2385294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis.
    Davis RL; Cheng PF; Lassar AB; Thayer M; Tapscott S; Weintraub H
    Princess Takamatsu Symp; 1989; 20():267-78. PubMed ID: 2562185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
    Spinner DS; Liu S; Wang SW; Schmidt J
    J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a thyroid hormone response element in the mouse myogenin gene: characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site.
    Downes M; Griggs R; Atkins A; Olson EN; Muscat GE
    Cell Growth Differ; 1993 Nov; 4(11):901-9. PubMed ID: 8297796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression.
    Li L; Chambard JC; Karin M; Olson EN
    Genes Dev; 1992 Apr; 6(4):676-89. PubMed ID: 1313772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimeric structures influence the binding activity of bHLH muscle regulatory factors.
    Wright WE; Catala F; Farmer K
    Symp Soc Exp Biol; 1992; 46():79-87. PubMed ID: 1341052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
    Maira SM; Wurtz JM; Wasylyk B
    EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin.
    Wang Y; Schnegelsberg PN; Dausman J; Jaenisch R
    Nature; 1996 Feb; 379(6568):823-5. PubMed ID: 8587605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative gene regulation in muscle.
    Nabeshima Y; Uetsuki T; Komiya T; Nabeshima Y; Asakura A; Kamijo K; Yagami T; Fujisawa-Sehara A
    Symp Soc Exp Biol; 1992; 46():343-53. PubMed ID: 1341047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential trans-activation of a muscle-specific enhancer by myogenic helix-loop-helix proteins is separable from DNA binding.
    Chakraborty T; Brennan T; Olson E
    J Biol Chem; 1991 Feb; 266(5):2878-82. PubMed ID: 1847137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental regulation of the Drosophila Tropomyosin I (TmI) gene is controlled by a muscle activator enhancer region that contains multiple cis-elements and binding sites for multiple proteins.
    Lin SC; Storti RV
    Dev Genet; 1997; 20(4):297-306. PubMed ID: 9254904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene.
    Hasty P; Bradley A; Morris JH; Edmondson DG; Venuti JM; Olson EN; Klein WH
    Nature; 1993 Aug; 364(6437):501-6. PubMed ID: 8393145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 2002 Sep; 41(35):10888-94. PubMed ID: 12196028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.